OCRA News

Anne van Harten, PhD | Meet a Scientist

Dr. Anne van Harten, of the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award…

Read on

OCRA-Funded Research Reveals How Distinct Mutational Processes May Affect HGSOC Tumor Growth

OCRA grantees Ignacio Vázquez-García, PhD and Sohrab Shah, PhD, of Memorial Sloan Kettering Cancer Center, along with colleagues, have found that distinct mutational processes determine the different mechanisms by which certain…

Read on

Sammy Ferri-Borgogno, PhD | Meet a Scientist

Dr. Sammy Ferri-Borgogno, of UT MD Anderson Cancer Center, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award…

Read on

Arun Kanakkanthara, PhD | Meet a Scientist

Dr. Arun Kanakkanthara, of Mayo Clinic, is a 2021 recipient of OCRA’s Liz Tilberis Early Career Award. With his project, “Exploiting a Metabolic Dependency of PARPinhibitor-Resistant Ovarian Cancer,” Dr…

Read on

Wei Zhou, PhD | Meet a Scientist

Dr. Wei Zhou, of The Wistar Institute in Philadelphia, is a 2021 recipient of OCRA’s Ann & Sol Schreiber Mentored Investigator Award, mentored by Dr. Rugang Zhang…

Read on

The Overview: December 2021

This time of year always has us reflecting on what we’ve accomplished, what we hope to achieve in the future, and how we — with the support of the entire ovarian cancer community — can lean in even harder to our commitment…

Read on

Announcing The Edmée Firth Fund for Research in Ovarian Cancer

Ovarian Cancer Research Alliance (OCRA) is proud to announce the establishment of a major new research partnership with Nicholas Firth and the Jean & Louis Dreyfus Foundation to be known as The Edmée Firth Fund for Research in Ovarian…

Read on

OCRA-Funded Research Identifies New “Master” Drug Targets for Ovarian Cancer

An interdisciplinary group of researchers from around the country analyzed tumor samples from nearly 10,000 patients with 34 types of cancer to reveal unique genetic switches associated with each tumor type…

Read on

Apply Today for OCRA’s 2022 Advocate Leader Program

The application period has now closed. Apply today to join survivors, caregivers and activists across the country to affect change for those impacted by ovarian cancer…

Read on

Liya Ding, PhD | Meet a Scientist

Dr. Liya Ding, of Dana-Farber Cancer Institute, is a 2021 recipient of OCRA’s Liz Tilberis Early Career Award. With her project, “Targeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer,” Dr…

Read on

How to Cope With Cancer

A cancer diagnosis of any type can stress both body and mind, but ovarian cancer takes a particularly high psychological toll on those living with the disease, according to recent research…

Read on

FDA Approves Drug to Identify Ovarian Cancer Lesions During Surgery

In what could prove to be a game-changer for ovarian cancer debulking procedures, the U.S…

Read on